PMID- 31599504
OWN - NLM
STAT- MEDLINE
DCOM- 20191022
LR  - 20191022
IS  - 1565-1088 (Print)
VI  - 21
IP  - 10
DP  - 2019 Oct
TI  - The Safety and Hemodynamic Effects of Pneumatic Sleeves in Patients with Severe 
      Left Ventricular Dysfunction.
PG  - 649-652
AB  - BACKGROUND: Pneumatic sleeves (PS) are often used during laparoscopic surgery and 
      for prevention of deep vein thrombosis in patients who cannot receive 
      anticoagulation treatment. There is very little information on the hemodynamic 
      changes induced by PS and their effect on brain natriuretic peptide (BNP) in 
      patients with severely reduced left ventricular ejection function (LVEF). 
      OBJECTIVES: To determine the safety and hemodynamic changes induced by PS and 
      their effects on brain natriuretic peptide (BNP). METHODS: This study comprised 
      14 patients classified as New York Heart Association (NYHA) II-III with severely 
      reduced LVEF (< 40%). We activated the PS using two inflation pressures (50 or 80 
      mmHg, 7 patients in each group) at two cycles per minute for one hour. We 
      measured echocardiography, hemodynamic parameters, and BNP levels in each patient 
      prior to, during, and after the PS operation. RESULTS: The baseline LVEF did not 
      change throughout the activation of PS (31 +/- 10% vs. 33 +/- 9%, P = 0.673). 
      Following PS activation there was no significant difference in systolic or 
      diastolic blood pressure, the pulse measurements, or central venous pressure. BNP 
      levels did not change after PS activation (P = 0.074). CONCLUSIONS: The use of 
      PS, with either low or high inflation pressures, is safe and has no detrimental 
      effects on hemodynamic parameters or BNP levels in patients with severely reduced 
      LVEF following clinical stabilization and optimal medical therapy.
FAU - Moady, Gassan
AU  - Moady G
AD  - Department of Cardiology, Galilee Medical Center, Nahariya, Israel.
FAU - Bickel, Amitai
AU  - Bickel A
AD  - Department of Surgery, Galilee Medical Center, Nahariya, Israel.
AD  - Azrieli Faculty of Medicine, Bar-Ilan University of the Galilee, Safed, Israel.
FAU - Shturman, Alexander
AU  - Shturman A
AD  - Department of Cardiology, Galilee Medical Center, Nahariya, Israel.
AD  - Azrieli Faculty of Medicine, Bar-Ilan University of the Galilee, Safed, Israel.
FAU - Khader, Muhammad
AU  - Khader M
AD  - Department of Cardiology, Galilee Medical Center, Nahariya, Israel.
FAU - Atar, Shaul
AU  - Atar S
AD  - Department of Cardiology, Galilee Medical Center, Nahariya, Israel.
AD  - Azrieli Faculty of Medicine, Bar-Ilan University of the Galilee, Safed, Israel.
LA  - eng
PT  - Journal Article
PL  - Israel
TA  - Isr Med Assoc J
JT  - The Israel Medical Association journal : IMAJ
JID - 100930740
RN  - 114471-18-0 (Natriuretic Peptide, Brain)
SB  - IM
MH  - Aged
MH  - Echocardiography
MH  - Female
MH  - Hemodynamics/*physiology
MH  - Humans
MH  - Intermittent Pneumatic Compression Devices/*adverse effects
MH  - Male
MH  - Natriuretic Peptide, Brain/blood
MH  - Ventricular Dysfunction, Left/blood/*physiopathology
EDAT- 2019/10/11 06:00
MHDA- 2019/10/23 06:00
CRDT- 2019/10/11 06:00
PHST- 2019/10/11 06:00 [entrez]
PHST- 2019/10/11 06:00 [pubmed]
PHST- 2019/10/23 06:00 [medline]
PST - ppublish
SO  - Isr Med Assoc J. 2019 Oct;21(10):649-652.